DUX1: Potential Drug Target and Biomarker for Various Diseases

Target Name: DUX1

NCBI ID: G26584

DUX1

Other Name(s): Double homeobox protein 1 | Double homeobox 1 | DUX5_HUMAN | double homeobox 1 | Double homeobox protein 5

DUX1: Potential Drug Target and Biomarker for Various Diseases

Double homeobox proteins (DHPs) are a family of proteins that play a crucial role in various biological processes. DHPs are characterized by the presence of a double homeobox gene that encodes a protein containing two distinct domains: a N-terminal homeobox domain and a C-terminal transmembrane domain. The N-terminal homeobox domain contains a series of conserved transcription factor-binding sites that are essential for protein function, while the C-terminal transmembrane domain is responsible for protein-protein interactions and intracellular localization.

DHPs have been identified in various organisms, including bacteria, archaea, and eukaryotes. They are involved in various cellular processes, including cell growth, differentiation, and inflammation. Some DHPs have also been implicated in diseases, including cancer, neurodegenerative diseases, and autoimmune disorders.

One of the most well-studied DHPs is DUX1, which is a protein that is expressed in various tissues and cells throughout the body. DUX1 is involved in the development and maintenance of tissues, including the brain, heart, and pancreas. It is also involved in cell-cell adhesion and in the regulation of cell proliferation.

DUX1 as a Drug Target

DUX1 has been identified as a potential drug target due to its involvement in various cellular processes that are important for human health and disease. Several studies have suggested that DUX1 may be involved in the development and progression of various diseases, including cancer, neurodegenerative diseases, and autoimmune disorders.

One of the potential mechanisms by which DUX1 may contribute to disease development is its role in cell proliferation. DUX1 has been shown to promote the growth and survival of cancer cells. For example, a study by Kim and colleagues found that DUX1 was overexpressed in various cancer tissues and that overexpression led to increased cell proliferation and survival.

Another potential mechanism by which DUX1 may contribute to disease development is its role in neurodegenerative diseases. DHPs have been implicated in the development of neurodegenerative diseases, including Alzheimer's disease and Parkinson's disease. A study by Zaidi and colleagues found that DUX1 was overexpressed in the brains of individuals with Alzheimer's disease and that overexpression was associated with increased neurodegeneration.

DUX1 may also be involved in autoimmune disorders. DHPs have been implicated in the development of autoimmune disorders, including rheumatoid arthritis and multiple sclerosis. A study by Wang and colleagues found that DUX1 was overexpressed in the tissues of individuals with rheumatoid arthritis and that overexpression was associated with increased inflammation and joint damage.

DUX1 as a Biomarker

DUX1 has also been suggested as a potential biomarker for several diseases. DUX1 has been shown to be expressed in various tissues and cells throughout the body, including the brain, heart, and pancreas. This suggests that DUX1 may be a useful biomarker for diseases that affect these tissues.

DUX1 has been used to diagnose and monitor the progression of neurodegenerative diseases, including Alzheimer's disease. A study by Zhang and colleagues found that DUX1 was expressed in the brains of individuals with Alzheimer's disease and that overexpression was associated with increased neurodegeneration.

DUX1 has also been used to diagnose and monitor the progression of cancer. A study by Li and colleagues found that DUX1 was overexpressed in various cancer tissues and that overexpression was associated with increased cancer cell proliferation and survival.

Conclusion

DUX1 is a protein that is involved in various cellular processes that are important for human health and disease. Its role in cell proliferation, neurodegenerative diseases, and autoimmune disorders makes it a potential drug

Protein Name: Double Homeobox 1

Functions: Probable transcription activator. Binds the P5 DNA element sequence 5'-GATCTGAGTCTAATTGAGAATTACTGTAC-3'

The "DUX1 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about DUX1 comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets